Effect of Ursodeoxycolic acid on neonatal jundice

Phase 3

Recruiting

• Conditions: hyperbilirubinemia.; Neonatal jaundice, unspecified; P59.9

• Registration Number: IRCT20220723055524N1
• Lead Sponsor: Babol University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 13 November 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 80

Inclusion Criteria

The criteria for inclusion in the study include full-term infants (37-41 weeks)
postnatal age greater than or equal to 72 hours
and weighing more than 2.5 kg
billirubin T<18

Exclusion Criteria

direct hyperbillirubinemia
symptoms of sepsis
prematurity

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Accelerate the reduction of bilirubin. Timepoint: Measurement of total bilirubin level at 12, 24, 36 and 48 hours. Method of measurement: Total bilirubin serum level by diazo method.

Secondary Outcome Measures

Name	Time	Method
Duration of hospitalization. Timepoint: During the study by measuring serum bilirubin. Method of measurement: measuring serum bilirubin.;Time of separation between mother and baby. Timepoint: During the study by measuring serum bilirubin. Method of measurement: measuring serum bilirubin.;Reducing treatment costs. Timepoint: During the study by measuring serum bilirubin. Method of measurement: measuring serum bilirubin.;Reducing parents' worries are secondary outcomes. Timepoint: During the study by measuring serum bilirubin. Method of measurement: measuring serum bilirubin.